Detalhe da pesquisa
1.
Safety of anti-IL-23 risankizumab treatment in a patient with severe psoriasis and Charcot-Marie-Tooth disease.
Australas J Dermatol
; 64(4): e376-e378, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698028